OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma

Feb 28, 2012 6:01am EST

OncoSec to Present at 10th Annual BioPartnering North America

Feb 24, 2012 6:01am EST

OncoSec Initiates Phase II Merkel Cell Carcinoma Study and Doses Several Patients

Feb 13, 2012 6:01am EST

OncoSec To Present at BIO CEO & Investor Conference

Feb 08, 2012 6:01am EST

OncoSec President and CEO Contributes to Physicians News Digest

Feb 01, 2012 6:01am EST

OncoSec to Present at World Cancer Immunotherapy Conference

Jan 24, 2012 6:01am EST

OncoSec Provides Company Update and Announces 2012 Goals

Jan 18, 2012 6:01am EST

OncoSec Medical President and CEO Contributes to Drug Discovery News

Jan 17, 2012 6:01am EST

OncoSec to Attend 30th Annual JP Morgan Healthcare Conference and Present at Investor Conferences in San Francisco

Jan 05, 2012 6:01am EST

OncoSec Medical Engages The Investor Relations Group

Dec 14, 2011 6:01am EST